Antipsychotic  	Antipsychotic  	 JJ	B-NP
long-acting  	long-acting  	 JJ	I-NP
injections 	injections 	 NNS	I-NP
:  	:  	 :	O
mind  	mind  	 VB	O
the  	the  	 DT	O
gap  	gap  	 NN	B-NP
Long-acting  	Long-acting  	 JJ	I-NP
injections  	injections  	 NNS	I-NP
of  	of  	 IN	I-NP
antipsychotic  	antipsychotic  	 JJ	I-NP
medication  	medication  	 NN	I-NP
( 	( 	 -LRB-	O
or  	or  	 CC	O
depots 	depots 	 NNS	O
)  	)  	 -RRB-	O
were  	were  	 VBD	O
developed  	developed  	 VBN	O
specifically  	specifically  	 RB	O
to  	to  	 TO	O
promote  	promote  	 VB	O
treatment  	treatment  	 NN	B-NP
adherence  	adherence  	 NNS	I-NP
and  	and  	 CC	O
are  	are  	 VBP	O
a  	a  	 DT	O
valuable  	valuable  	 JJ	O
option  	option  	 NN	O
for  	for  	 IN	O
maintenance  	maintenance  	 NN	B-NP
medication  	medication  	 NN	I-NP
in  	in  	 IN	O
psychotic  	psychotic  	 JJ	B-NP
illnesses 	illnesses 	 NNS	I-NP
.  	.  	 .	O
Approximately  	Approximately  	 RB	O
40-60 	40-60 	 CD	O
%  	%  	 NN	O
of  	of  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
schizophrenia  	schizophrenia  	 NNS	O
are  	are  	 VBP	O
partially  	partially  	 RB	O
or  	or  	 CC	O
totally  	totally  	 RB	O
non-adherent  	non-adherent  	 JJ	B-NP
to  	to  	 TO	O
their  	their  	 PRP$	O
antipsychotic  	antipsychotic  	 JJ	B-NP
regimen 	regimen 	 NN	I-NP
,  	,  	 ,	O
but  	but  	 CC	O
only  	only  	 RB	O
30 	30 	 CD	O
%  	%  	 NN	O
or  	or  	 CC	O
less  	less  	 JJR	O
are  	are  	 VBP	O
prescribed  	prescribed  	 VBN	O
a  	a  	 DT	O
long-acting  	long-acting  	 JJ	B-NP
injection 	injection 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
use  	use  	 NN	O
of  	of  	 IN	O
such  	such  	 JJ	O
injections  	injections  	 NN	O
has  	has  	 VBZ	O
declined  	declined  	 VBN	O
in  	in  	 IN	O
recent  	recent  	 JJ	O
years  	years  	 NNS	O
after  	after  	 IN	O
the  	the  	 DT	O
introduction  	introduction  	 NN	B-NP
of  	of  	 IN	I-NP
second-generation  	second-generation  	 NNP	I-NP
( 	( 	 -LRB-	O
atypical 	atypical 	 LS	O
)  	)  	 -RRB-	O
oral  	oral  	 JJ	B-NP
antipsychotic  	antipsychotic  	 JJ	I-NP
drugs 	drugs 	 NNS	I-NP
.  	.  	 .	O
Research  	Research  	 NNP	O
shows  	shows  	 VBZ	O
that  	that  	 DT	O
possible  	possible  	 JJ	O
reasons  	reasons  	 NNS	O
for  	for  	 IN	O
this  	this  	 DT	O
decline  	decline  	 NN	O
include  	include  	 VBP	O
concerns  	concerns  	 NNS	O
that  	that  	 WDT	O
may  	may  	 MD	O
be  	be  	 VB	O
based  	based  	 VBN	O
on  	on  	 IN	O
suboptimal  	suboptimal  	 JJ	B-NP
knowledge 	knowledge 	 NN	I-NP
,  	,  	 ,	O
as  	as  	 RB	O
well  	well  	 RB	O
as  	as  	 IN	O
an  	an  	 DT	O
erroneous  	erroneous  	 JJ	B-NP
assumption  	assumption  	 NN	I-NP
that  	that  	 IN	O
one 	one 	 NN	O
's  	's  	 POS	O
own  	own  	 JJ	O
patient  	patient  	 NN	O
group  	group  	 NN	O
is  	is  	 VBZ	O
more  	more  	 JJR	O
adherent  	adherent  	 NN	B-NP
than  	than  	 IN	O
those  	those  	 DT	O
of  	of  	 IN	O
one 	one 	 NN	O
's  	's  	 POS	O
colleagues 	colleagues 	 NNS	O
.  	.  	 .	O
Research  	Research  	 NN	O
on  	on  	 IN	O
attitudes  	attitudes  	 NNS	O
has  	has  	 VBZ	O
also  	also  	 RB	O
revealed  	revealed  	 VBN	O
that  	that  	 IN	O
psychiatrists  	psychiatrists  	 NNS	O
feel  	feel  	 VBP	O
that  	that  	 IN	O
long-acting  	long-acting  	 JJ	B-NP
injections  	injections  	 NNS	I-NP
have  	have  	 VBP	O
an  	an  	 DT	O
; 	; 	 :	O
image 	image 	 NN	O
'  	'  	 POS	O
problem 	problem 	 NN	O
.  	.  	 .	O
This  	This  	 DT	O
editorial  	editorial  	 NN	O
addresses  	addresses  	 VBZ	O
the  	the  	 DT	O
gaps  	gaps  	 NN	O
in  	in  	 IN	O
knowledge  	knowledge  	 NN	O
and  	and  	 CC	O
behaviour  	behaviour  	 VB	O
associated  	associated  	 VBN	O
with  	with  	 IN	O
possible  	possible  	 JJ	O
underutilisation  	underutilisation  	 NN	B-NP
of  	of  	 IN	O
these  	these  	 DT	O
formulations 	formulations 	 NN	B-NP
,  	,  	 ,	O
highlighting  	highlighting  	 VBG	O
the  	the  	 DT	O
role  	role  	 NN	O
of  	of  	 IN	O
stigma  	stigma  	 NN	O
and  	and  	 CC	O
the  	the  	 DT	O
need  	need  	 NN	O
for  	for  	 IN	O
more  	more  	 JJR	O
research 	research 	 NN	O
.  	.  	 .	O
